Gang Huang

Title: Innovations and Contributions of Inventor Gang Huang

Introduction

Gang Huang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of methods and compounds that have potential therapeutic applications. With a total of six patents to his name, Huang's work reflects a commitment to advancing scientific knowledge and practical solutions.

Latest Patents

Huang's latest patents include a method for preparing immobilized arginine deiminase (ADI) and producing [N]-L-citrulline. This involves the use of a genetically engineered fusion protein, cipA-arc, which has a deposit number of CGMCC No. 19404. Both the genetically engineered strain and the fusion protein can convert [N]-L-arginine into [N]-L-citrulline. Additionally, he has developed an isoindol-sulfilimine compound that serves as a sigma-2 receptor inhibitor. This compound effectively inhibits sigma-2 receptor activity, which can lead to the removal of Aβ oligomers from synapses, offering potential for new therapeutic drugs for tumor and neurodegenerative diseases.

Career Highlights

Gang Huang has worked with notable institutions, including Shanghai University of Medicine & Health Sciences and Otis Elevator Company. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative research.

Collaborations

Huang has collaborated with esteemed colleagues such as Shenhong Wang and Bin Li. These partnerships have likely enhanced the scope and impact of his research endeavors.

Conclusion

Gang Huang's innovative work and patents demonstrate his significant contributions to biotechnology and therapeutic development. His research continues to pave the way for advancements in medical science and treatment options.